Multiplex-GCN Predicts Clinically Actionable Tumor Microenvironment Subtypes in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. It has a five-year survival rate of approximately 13%, largely due to late diagnosis, rapid metastasis, and limited therapeutic options. The tumor microenvironment (TME), including immune and non-immune cells, plays a role in PDAC progression and drug resistance. However, molecular characteristics of PDAC based…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
